ID   eHAP A11
AC   CVCL_5J32
SY   eHAPA11; Engineered-HAPloid clone A11
DR   cancercelllines; CVCL_5J32
DR   Wikidata; Q54832106
RX   PubMed=25373145;
CC   Group: Haploid karyotype cell line.
CC   Sequence variation: Gene fusion; HGNC; 76; ABL1 + HGNC; 1014; BCR; Name(s)=BCR-ABL1, BCR-ABL; Note=BCR exon 13 fused to ABL1 exon 2 (b2a2 transcript) (from parent cell line).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Ser215Gly (c.643A>G); ClinVar=VCV000265337; Zygosity=Hemizygous (from parent cell line).
CC   Omics: Genome sequenced.
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
DI   NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
DI   ORDO; Orphanet_521; Chronic myeloid leukemia
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_Y019 ! HAP1
SX   Male
AG   40Y
CA   Cancer cell line
DT   Created: 14-12-15; Last updated: 02-05-24; Version: 12
//
RX   PubMed=25373145; DOI=10.1101/gr.177220.114;
RA   Essletzbichler P., Konopka T., Santoro F., Chen D., Gapp B.V.,
RA   Kralovics R., Brummelkamp T.R., Nijman S.M.B., Burckstummer T.;
RT   "Megabase-scale deletion using CRISPR/Cas9 to generate a fully haploid
RT   human cell line.";
RL   Genome Res. 24:2059-2065(2014).
//